Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $3.58 $6.48 Friday, 10th May 2024 FATE stock ended at $4.08. This is 4.62% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 17.83% from a day low at $3.67 to a day high of $4.33.
90 days $3.58 $8.83
52 weeks $1.63 $8.83

Historical Fate Therapeutics prices

Date Open High Low Close Volume
Oct 21, 2016 $2.50 $2.50 $2.38 $2.38 45 900
Oct 20, 2016 $2.41 $2.50 $2.41 $2.50 22 500
Oct 19, 2016 $2.49 $2.53 $2.38 $2.40 70 900
Oct 18, 2016 $2.45 $2.51 $2.36 $2.47 64 800
Oct 17, 2016 $2.51 $2.54 $2.38 $2.42 85 800
Oct 14, 2016 $2.56 $2.71 $2.49 $2.55 63 000
Oct 13, 2016 $2.65 $2.67 $2.50 $2.53 195 500
Oct 12, 2016 $2.96 $2.97 $2.66 $2.69 118 800
Oct 11, 2016 $2.93 $2.99 $2.87 $2.95 53 400
Oct 10, 2016 $2.88 $2.97 $2.82 $2.94 81 100
Oct 07, 2016 $2.97 $3.06 $2.85 $2.86 61 400
Oct 06, 2016 $3.03 $3.03 $2.85 $2.97 115 600
Oct 05, 2016 $3.05 $3.13 $2.91 $3.07 111 200
Oct 04, 2016 $3.02 $3.12 $2.96 $3.01 71 100
Oct 03, 2016 $3.10 $3.12 $2.89 $3.04 84 200
Sep 30, 2016 $3.00 $3.15 $2.98 $3.12 127 500
Sep 29, 2016 $3.09 $3.13 $2.98 $3.02 130 300
Sep 28, 2016 $3.29 $3.29 $3.04 $3.07 184 900
Sep 27, 2016 $3.43 $3.47 $3.05 $3.26 455 100
Sep 26, 2016 $3.58 $3.67 $3.36 $3.41 339 700
Sep 23, 2016 $3.58 $3.63 $3.30 $3.44 358 400
Sep 22, 2016 $3.32 $3.82 $3.30 $3.54 786 700
Sep 21, 2016 $3.24 $3.32 $3.10 $3.18 266 900
Sep 20, 2016 $3.03 $3.23 $2.90 $3.19 278 000
Sep 19, 2016 $3.05 $3.23 $2.82 $3.00 302 500
Click to get the best stock tips daily for free!

About Fate Therapeutics

Fate Therapeutics Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT